Giuseppe De Luca

Showing 1-8 of 8 articles

Coronary interventions

EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI) A branch of the European Society of Cardiology

Van Belle E, Teles RC, Pyxaras S, Kalpak O, Johnson T, Barbash IM, De Luca G, Kostov J, Parma R, Vincent F, Brugaletta S, Debry N, Toth G, Ghazzal Z, Deharo P, Milasinovic D, Kaspar K, Saia F, Mauri J, Kammler J, Muir D, O'Connor S, Mehilli J, Thiele H, Weilenmann D, Witt N, Joshi F, Kharbanda R, Piroth Z, Wojakowski W, Geppert A, Di Gioia G, Pires-Morais G, Petronio A, Estevez-Loureiro R, Ruzsa Z, Kefer J, Kunadian V, Van Mieghem N, Windecker S, Baumbach A, Haude M, Dudek D

July 7, 2020 | 10.4244/EIJ-D-18-00448

Coronary interventions

Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)

De Luca G, Damen S, Camaro C, Benit E, Verdoia M, Rasoul S, Liew H, Polad J, Ahmad W, Zambahari R, Postma S, Kedhi E, Suryapranata H

December 6, 2019 | 10.4244/EIJ-D-19-00539

Coronary interventions

Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial

Schoos M, De Luca G, Dangas G, Clemmensen P, Ayele G, Mehran R, Stone G

October 20, 2016 | 10.4244/EIJV12I9A186

Coronary interventions

Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon

Secco G, Ghione M, Mattesini A, Dall’Ara G, Ghilencea L, Kilickesmez K, De Luca G, Fattori R, Parisi R, Marino P, Lupi A, Foin N, Di Mario C

June 20, 2016 | 10.4244/EIJY15M06_04

Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation

De Luca G, Gibson C, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van’t Hof A

August 24, 2012 | 10.4244/EIJV8I4A74

Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials

Navarese E, Kubica J, Castriota F, Gibson M, De Luca G, Buffon A, Bolognese L, Margheri M, Andreotti F, Di Mario C, De Servi S

December 30, 2011 | 10.4244/EIJV7I8A155

Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons

Secco G, Foin N, Msc M, Viceconte N, Borgia F, De Luca G, Di Mario C

November 30, 2011 | 10.4244/EIJV7I7A130

Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis

Biondi-Zoccai G, Moretti C, Abbate A, Lipinski M, De Luca G, Agostoni P, Meliga E, Goudreau E, Vetrovec G, Trevi GP, Sheiban I

November 20, 2007

1

Latest news

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Tetralogy of Fallot with acquired double right ventricular outflow tract

September 18, 2020

Ahead of print: Leaflex Study

September 23, 2020

Integrating physiology in OCT

September 23, 2020

VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more

(The Trials book is supported by Biotronik)

August 28, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Steady-state hyperaemia

September 18, 2020

This Week's JAA's: Biograde Study, Advances in valvular heart interventions...

September 22, 2020

Valvular disease